March 8, 2018 Price forecast | 2 weeks: -2.94% | 1 month: -2.89% | 3 months: -2.65%


CBIO stock forecast

Our latest prediction for Catalyst Biosciences, Inc.'s stock price was made on the March 8, 2018 when the stock price was at 28.59$.

In the short term (2weeks), CBIO's stock price should underperform the market by -2.94%. During that period the price should oscillate between -12.98% and +15.91%.

In the medium term (3months), CBIO's stock price should underperform the market by -2.65%. During that period the price should oscillate between -27.23% and +36.13%.


About Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -2.71$ per share.

The book value per share is 11.47$

Catalyst Biosciences, Inc. website


Three months stock forecastMarch 8, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -28M - -25M -2.71 - - 9M 11.47 -26M - -26M